Cover Image

Ruxolitinib cream for the treatment of cutaneous sarcoidosis

Saved in:

Bibliographic Details
Main Authors:	Jeffrey S. Smith, MD, PhD (Author), Michael J. Woodbury, BS (Author), Joseph F. Merola, MD, MMSc (Author)
Format:	Book
Published:	Elsevier, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of cutaneous lupus with topical ruxolitinib cream
by: Jonathan J. Park, PhD, et al.
Published: (2022)

Ruxolitinib cream for the treatment of granuloma annulare
by: Austin J. Piontkowski, BS, et al.
Published: (2024)

Anifrolumab for the treatment of refractory chilblain lupus erythematosus
by: Michael J. Woodbury, BS, et al.
Published: (2024)

Topical steroid withdrawal treated with ruxolitinib cream
by: Moira Shea, BS, et al.
Published: (2024)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
by: Juna Khang, BA, et al.
Published: (2023)

Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream
by: Sophia S. Tran, BS, et al.
Published: (2024)

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
by: Shannon Nugent, BS, et al.
Published: (2022)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
by: Aviya Lanis, MD, et al.
Published: (2024)

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
by: Michael J. Woodbury, BS, et al.
Published: (2023)

Discoid lupus erythematosus of the nail treated with thalidomide
by: Taylor Harp, DO, et al.
Published: (2023)

The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
by: Deesha Desai, BS, et al.
Published: (2024)

Intravenous immunoglobulin-refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
by: Neda Shahriari, MD, et al.
Published: (2023)

Cutaneous sarcoidosis possibly associated with aromatase inhibitors and tamoxifen
by: Tomoya Sawada, MD, et al.
Published: (2023)

Letter in response to the case report "Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis"
by: Meron Teklu, MD, et al.
Published: (2023)

Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report
by: Mohannad Safadi, MD, et al.
Published: (2024)

Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
by: Mariam Alam, MD, et al.
Published: (2021)

Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
by: Paul Smith, et al.
Published: (2021)

Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient
by: Danielle M. Peterson, MD, et al.
Published: (2020)

Tattoo pruritus successfully treated with ruxolitinib: A case series
by: Julianna Shin, BS, et al.
Published: (2024)

Delayed granulomatous eruption of the nose associated with ruxolitinib
by: Margaret Brown, MD, et al.
Published: (2020)

Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab
by: Rebecca G. Gaffney, MD, et al.
Published: (2024)

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
by: Andrew Blauvelt, et al.
Published: (2024)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
by: Noreen Mohsin, BS, et al.
Published: (2022)

Topical ruxolitinib for the treatment of granuloma faciale
by: Alan Wong, DO, et al.
Published: (2023)

Quantification of granuloma volume and response to treatment in cutaneous sarcoidosis using 3-dimensional high-frequency ultrasound scan
by: Olaf Rodriguez, BS, et al.
Published: (2017)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017)

Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
by: Michael D. Howell, et al.
Published: (2023)

Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
by: Lawrence F. Eichenfield, et al.
Published: (2024)

Upper portion of the eyelid blepharoplasty for a patient with recalcitrant Morbihan disease
by: Michael J. Woodbury, BS, et al.
Published: (2023)

Morpheaform sarcoidosis: A case presentation of an uncommon cutaneous manifestation of sarcoidosis
by: Kimberly B. Hashemi, MD, et al.
Published: (2021)

Cutaneous Sarcoidosis
by: Sayal S.K, et al.
Published: (2001)

Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib
by: Arianna Zhang, BS, et al.
Published: (2024)

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years
by: John E. Harris, et al.
Published: (2024)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
by: Eleanor Pope, BA, et al.
Published: (2022)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021)

Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib
by: Hannah L. Cornman, BS, et al.
Published: (2023)

Chronic recurrent annular neutrophilic dermatosis revealing sarcoidosis
by: Fanny Philibert, BS, et al.
Published: (2020)

A case of cutaneous sarcoidosis with pulmonary involvement after SARS-CoV-2 mRNA vaccination
by: Jung Eun Seol, MD, PhD, et al.
Published: (2024)

Extension-elicited blanching of the dorsal phalanges in systemic sclerosis: A case series
by: Elisa M. Schunkert, MD, et al.
Published: (2022)